Octavius Pharma has developed DC granules of Olanzapine for making Olanzapine plain tablets. The product has been developed to produce uniform particles that help give excellent flowability in a way that facilitates tablet compression to maintain content uniformity and common granules compatible with compression for all strengths. The finished tablet’s qualitative composition is in line with the innovator “Zyprexa”; the product complies as per the USP monograph.
| Strength | 2.5 / 5 / 7.5 / 10 / 20 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | USP |
| API DMF | Available |
| CTD Dosssier | Available |
Olanzapine: Olanzapine is used in the treatment of schizophrenia and mania. It is an atypical antipsychotic. It works by affecting the levels of chemical messengers (dopamine and serotonin) to improve mood, thoughts, and behavior.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields